CBD Products & CBD Business News

GW Pharmaceuticals poised to raise $300 million in stock offering

Cannabis biopharmaceutical company  GW Pharmaceuticals is setting out to sell $300 million worth of U.S. depository shares. The London-based company’s announcement comes on the heels of the U.S. Drug Enforcement Administration’s move to take some cannabidiol products off the most restrictive class of controlled substances. That change will allow Epidiolex – a CBD drug manufactured by GW Pharmaceuticals […]

Read More

FDA: CBD shouldn’t be a controlled substance, but treaties require it

The U.S. Food and Drug Administration noted that cannabidiol shouldn’t be a controlled substance, but international treaties require the United States to treat it as one. That revelation from the federal agency appeared in a 27-page memo written after it approved the first drug made with CBD earlier this year. “CBD has negligible potential for abuse,” wrote Dr. Brett […]

Read More

What Farm Bill? Hemp industry shrugs off law’s expiration

The law that ushered in the modern hemp industry in the United States has expired, but hemp growers, processors and retailers are counting on legal assurances that the nation’s experiment in allowing limited hemp production won’t immediately end.

The 2014 Farm Bill, which authorized hemp production under state research programs, expired Sunday – the last day of the federal fiscal year.

Read More

Australian CBD maker raises $29 million, ups investment in Japan

Australian CBD company Elixinol Global raised 40 million Australian dollars ($29 million) in a new share placement to ramp up sales and marketing efforts in the United States and Europe. The capital raise comes less than a week after the company announced its wholly owned subsidiary, EXL International Holdings, increased its stake in Hemp Foods Japan, from […]

Read More

DEA takes some CBD off Schedule 1 – with FDA approval

The U.S. Drug Enforcement Administration has taken some cannabidiol off the most restrictive class of controlled substances, a move that allows the sale of the first nonsynthetic, cannabis-derived medicine to win federal approval.

The agency announced Thursday that drugs including “finished dosage formulations” of CBD with THC below 0.1% will be considered Schedule 5 drugs, as long as the medications have been approved by the U.S. Food and Drug Administration.

Read More

Multistate medical marijuana operators tapped for Virginia’s CBD program

Virginia named its first five CBD-only medical cannabis business licensees – three of them multistate operators. Virginia’s Board of Pharmacy reviewed 51 applicants to produce CBD products in five areas of the state. The winning applicants are called “pharmaceutical processors” and must grow, process and sell the products at one location, though Virginia patients can visit any […]

Read More

‘One day you’re legal, the next day you’re not’: Confusion from spotty CBD enforcement

CBD producers and retailers in some of the nation’s largest markets say they’re pressing on despite hostile statements from their state regulators that CBD won’t be allowed. Bans in several markets have largely been met with spotty enforcement, CBD entrepreneurs say, and the impact to business has been mixed. Ohio is one of the latest […]

Read More

Coca-Cola eyes CBD ‘functional wellness beverages’ as soda market cools

The Coca-Cola Co., the world’s largest beverage maker, is looking at a line of CBD beverages, the company confirmed Monday. “Along with many others in the beverage industry, we are closely watching the growth of nonpsychoactive CBD as an ingredient in functional wellness beverages around the world,” Coca-Cola spokesman Kent Landers said in a statement. “The space is […]

Read More

Capitalizing on CBD: How hemp businesses are shaping the market and winning new customers

Dr. Priyanka Sharma had a thriving global business in chemical pharmaceuticals, traveling the world setting up factories extracting fish oil for nutritional supplements.

But Sharma and her husband, Pulak, left their home outside Chicago and moved to Colorado for the same three letters that have cannabis entrepreneurs, pharmaceutical companies and even mainstream grocers seeing dollar signs: CBD.

Read More

Aurora makes big move into European hemp, CBD market

Continuing its global acquisition spree, Aurora Cannabis acquired two Lithuanian hemp companies for 6.3 million euros ($7.3 million) in cash and stocks. Edmonton, Alberta-based Aurora acquired hemp grower and processor Agropro UAB, which has some 4,000 acres growing hemp, and Agropro’s sister company, Borela UAB, which processes and distributes organic hulled hempseeds, hempseed protein, hemp flour […]

Read More